Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

February is Heart Month, and for one woman in Hampton Roads, that has literal meaning. Tina Buck, 46, has the distinction of being one of the longest surviving heart ...

Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...